---
title: "Fresenius Medical Care AG : Release of a capital market information"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293197669.md"
description: "Fresenius Medical Care AG disclosed an interim report on its share buyback program. Between July 13 and July 17, 2026, the company repurchased a total of 3,294,040 shares through the XETR trading venue. The weighted average purchase price ranged from approximately EUR 41.55 to EUR 42.53 per share. This activity is part of the first tranche of the buyback announced in May 2026."
datetime: "2026-07-20T10:14:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293197669.md)
  - [en](https://longbridge.com/en/news/293197669.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293197669.md)
generator: "portal-rs"
---

# Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

Fresenius Medical Care AG : Release of a capital market information

20.07.2026 / 12:14 CET/CEST

Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group.

The issuer is solely responsible for the content of this announcement.

Fresenius Medical Care AG: Share buyback

**Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014**

Share buyback – Interim Report

In the period from July 13, 2026 to July 17, 2026 (each inclusive), 336,000 shares were bought back within the framework of the first tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on May 28, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

Shares were bought back as follows:

**Date**

**Acquired shares (number)**

**Weighted average price (in EUR)**

**Transaction volume** **(in EUR)**

**Trading venue**

13 July 2026

31,000

42.3704

1,313,482.40

XETR

14 July 2026

1,000

42.5343

42,534.30

XETR

15 July 2026

140,000

41.5538

5,817,532.00

XETR

16 July 2026

84,000

41.9386

3,522,842.40

XETR

17 July 2026

80,000

42.2066

3,376,528.00

XETR

A total of 3,294,040 shares has been acquired within the framework of the first tranche of the share buyback.

The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG.

Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.

20.07.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Language:

English

Company:

Fresenius Medical Care AG 

Else-Kröner-Straße 1

61352 Bad Homburg

Germany

Internet:

www.freseniusmedicalcare.com

LEI Code:

549300CP8NY40UP89Q40

End of News

EQS News Service

2368546 20.07.2026 CET/CEST 

**Disclaimer**

Saving the news in databases or any forwarding of the news to third parties in a commercial context or for commercial purposes is only permitted with the prior written consent of EQS Group AG.

### Related Stocks

- [FME.DE](https://longbridge.com/en/quote/FME.DE.md)
- [FMS.US](https://longbridge.com/en/quote/FMS.US.md)
- [EQS.DE](https://longbridge.com/en/quote/EQS.DE.md)

## Related News & Research

- [BlackRock trims Fresenius Medical Care voting rights stake to 6.63% from 7%](https://longbridge.com/en/news/297496680.md)
- [Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation | AMWL Stock News](https://longbridge.com/en/news/297903928.md)
- [REG - BlackRock Group Adv Medical Solutns. - Form 8.3 - Advanced Medical Solutions Group plc](https://longbridge.com/en/news/297929095.md)
- [12:20 ETMemorialCare Rehabilitation Institute at Long Beach Medical Center Earns Exemplary Three-Year CARF Accreditation for Eighth Consecutive Time](https://longbridge.com/en/news/297939929.md)
- [REG - BlackRock Group Adv Medical Solutns. - Form 8.3 - Advanced Medical Solutions Group plc](https://longbridge.com/en/news/297800407.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**